Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Osteoporosis 4 Prostatic Neoplasms 3 Breast Neoplasms 3 Vitamin D Deficiency 2 Polycystic Ovary Syndrome 2 Neoplasms 2 Cardiovascular Diseases 2 Vitamin D3 1 Neuroma 1 Melanoma, Cutaneous Malignant 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Locally Advanced Breast Cancer and Large Operable Breast Cancer 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Insulin Resistance 1 Fractures, Bone 1 Colorectal Adenocarcinoma 1

Interventions

ofatumumab 3 venetoclax 2 pirtobrutinib 2 obinutuzumab 2 ibrutinib 2 Chlorambucil 2 acalabrutinib 1 Tablets 1 Observation 1 Cholecalciferol 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leukemia, B-Cell × Cholecalciferol × Clear all

NCT01518959 2020-07-16

D-HEM

Semmelweis University

Phase 3 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡